Deal reflects Liberty Mutual\'s conviction to its focused Asia Pacific strategy BOSTON,March 3,2025-- Liberty Mutual Insurance has agreed to sell its operations in Thailand and Vietnam to Chubb Limit
READ MORESTOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) are approved by FDA for all indications of reference products PROLIA® (denosumab) and XGEVA® (denosumab) respectively[1],[2]
BARCELONA,Spain,March 5,2025-- On March 3,as the global communications and technology community converged in Barcelona,forMWC Barcelona 2025,Yangtze Optical Fibre and Cable Joint Stock Limited Company
Info-Tech Research Group\'s premier IT event arrives in Australia for the first time,offering actionable insights to IT leaders and professionals in the APAC region on the future of technology. The i
Australia\'s largest celebration for Small Business Excellence SYDNEY,Nov. 21,2024--Entries have officially opened for the 2025 Australian Small Business Champion Awards - the nation\'s premier award
HONG KONG,Nov. 21,2024-- Asian Venture Capital Journal (AVCJ),part of Mergermarket and the leading provider of private equity and venture capital intelligence in Asia,this week hosted its 37th Annual
HONG KONG,Nov. 21,2024-- Kerry Logistics Network Limited (\'KLN\'; Stock Code 0636.HK)is pleased to announce the appointment of Wong Siew Loong as its Chief Commercial Officer for the Group and Managi
Tuesday,December 31,2024 – Monday,January 13,2025 (National holiday) TOKYO,Nov. 21,2024-- BELLUSTAR TOKYO,A Pan Pacific Hotel and HOTEL GROOVE SHINJUKU,A PARKROYAL Hotel (Shinjuku-ku,Tokyo;GeneralM
BEIJING,Nov. 19,2024-- China\'s continuous improvement of air quality and reduction of greenhouse gas emissions has benefited not only the country itself,but also the rest of Asia and the world,foreig
Prioritizing research integrity with enhanced filters to address publication and citation manipulation
BEIJING,Nov. 19,2024-- In a fully equipped laboratory in Beijing,a dragon-head architectural component from the Tang Dynasty (618-907) discovered at theGuzhou ruins in Xiong\'an New Area,North China\'
TAIPEI,Nov. 19,2024-- TAHO Pharmaceuticals Ltd. announced the dosing of the first subjects in its U.S. Phase III clinical trial for its lead product,TAH3311,an innovative antithrombotic oral dissolvin
New global survey by Heidrick & Struggles,BCG,and INSEAD,reveals growing confidence in sustainability governance,but boards and CEOs still lack confidence in each other\'s leadership
© OfficialAffairs
